HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan S&E

This article was originally published in The Rose Sheet

Executive Summary

Fine fragrance sales increased strong double-digits in the first half of the year, fueled by new wins and successes in the specialty retail segment and direct selling channels, Givaudan reports in six-month results issued Aug. 14. Consumer products sales advanced high single-digits on growth in all regions, according to the firm. Fragrance division sales, however, fell 3.3% to $412.2 mil. (CHF1=$.73) on a reported basis, while in local currencies, division sales increased 5.5%. Net sales dropped 7.4% to $1 bil. on a pro forma basis, assuming the acquisition of Nestle's flavor activities had taken place on Jan. 1, 2001, but were up 1.1% on a reported basis. Net profit for the six months fell 23.1% to $95.2 mil. on a pro forma basis...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel